NIAID Grants $3.5 Million for Anthrax Vaccine Study

The National Institute of Allergy and Infectious Diseases yesterday announced a $3.5 million federal grant to a Seattle research team for a study that could lead to an improved military anthrax vaccine, the Associated Press reported (see GSN, Oct. 28).

The team at the Benaroya Research Institute has developed artificial molecules called “tetramers,” which could provide a more accurate test that could assist in development of an improved vaccine.

The effectiveness of vaccines is generally measured by the production of antibodies, according to lead researcher Gerald Nepom. That method is slow, indirect and incapable of evaluating the level of protection, he said.

“It’s like following footprints in the sand rather than watching someone as they run by,” he said.

With tetramers, scientists can directly observe the vaccine’s effectiveness, Nepom added (Associated Press/KGW.com Nov. 2).

Back to top
About Newswire  |  Contact National Journal  |  Re-Use Guidelines © Copyright 2008 by National Journal Group, Inc. The material in this section is produced independently for NTI by National Journal Group, Inc. Any reproduction or retransmission, in whole or in part, is a violation of federal law and is strictly prohibited without the consent of the National Journal Group, Inc. All rights reserved.